GlassScriptPhysician profile
Frank M Moore
NPI 1760459374
$7,936.32
in general payments reported to CMS, 2019-2025
16 companies · $932 in 2025
The $932 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $714 · 2021: $141 · 2022: $1,920 · 2023: $1,659 · 2024: $2,406 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,992 · Travel and Lodging: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,992.10 |
| Travel and Lodging | $1,005.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $3,663.01 | 2019-2025 | Symphony, Expedium, Trialtis |
| Globus Medical, INC. | $1,387.36 | 2022-2023 | Excelsiusgps Robotic Navigation System |
| Medical Device Business Services, INC. | $1,206.04 | 2024 | Velys, Teligen |
| Neo Spine USA, INC. | $414.43 | 2020 | |
| Nevro Corp. | $290.57 | 2020-2021 | |
| Medtronic, INC. | $219.23 | 2025 | Mazor X System, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Osseus Fusion Systems, LLC | $150.00 | 2024 | |
| Abbott Laboratories | $149.99 | 2020 | |
| Highridge Medical LLC | $112.14 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Royal Biologics, INC. | $100.07 | 2024 | |
| Zimmer Biomet Holdings, INC. | $66.40 | 2022 | |
| Si-Bone, INC. | $63.05 | 2023 | |
| Medtronic USA, INC. | $40.63 | 2019 | |
| Alphatec Spine, INC | $28.87 | 2024 | Solus Alif |
| Augmedics INC. | $28.31 | 2024 | Xvision |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.